Immpro
Immpro provides top-down proteoform analysis using single-particle mass spectrometry, enabling researchers to study intact proteins rather than fragmented peptides. The platform supports any specimen, target, or disease, offering end-to-end support for research projects, database development, and AI model training to accelerate biomarker discovery and biological insights.
- Biotechnology
- Data & Analytics
- Artificial Intelligence
Funding
Raised to date
$120KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Founder details are not available yet.
Product
Problem
Traditional proteomics relies on peptide-based measurements, which fragment proteins and lose the critical information encoded in intact proteoforms. This limits researchers' ability to identify disease-specific biomarkers and fully understand complex biological processes, particularly when dealing with challenging specimens or targets.
Solution
Immpro offers top-down proteoform analysis powered by single-particle mass spectrometry, allowing researchers to analyze intact proteoforms directly rather than inferring information from digested peptides. The platform is designed to work with any specimen, target, or disease, providing comprehensive support for research projects, database development, and AI model training. By preserving the native state of proteoforms, the technology enables more accurate biomarker discovery and deeper insights into biological mechanisms. The company positions itself as an end-to-end partner, helping researchers navigate complex analytical workflows.
Target Audience
Primary customers are academic and industry researchers in proteomics, biomarker discovery, and precision medicine who require intact proteoform-level insights for complex biological questions.
Features
- Single-particle mass spectrometry technology for high-resolution analysis of intact proteoforms
- Top-down analytical approach that preserves full proteoform structure and post-translational modifications
- Cross-specimen and cross-target compatibility supporting diverse research applications
- Dedicated support for research projects, proteoform database development, and AI/ML stack integration
- Services applicable across any disease area, enabling broad translational research